Astex Joins Cancer Drug Discovery Collaboration | GenomeWeb

NEW YORK, March 22 (GenomeWeb News) - Astex Technology has formed an exclusive collaboration with The Wellcome Trust, the Institute of Cancer Research, and Cancer Research Technology to discover novel drugs against the cancer target BRAF, the partners said today.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.